###begin article-title 0
LDL-cholesterol concentrations: a genome-wide association study
###end article-title 0
###begin p 1
Contributed equally
###end p 1
###begin p 2
Members listed at end of paper
###end p 2
###begin p 3
This document may be redistributed and reused, subject to .
###end p 3
###begin title 4
Summary
###end title 4
###begin title 5
Background
###end title 5
###begin p 6
LDL cholesterol has a causal role in the development of cardiovascular disease. Improved understanding of the biological mechanisms that underlie the metabolism and regulation of LDL cholesterol might help to identify novel therapeutic targets. We therefore did a genome-wide association study of LDL-cholesterol concentrations.
###end p 6
###begin title 7
Methods
###end title 7
###begin p 8
###xml 55 67 <span type="species:ncbi:9606">participants</span>
###xml 375 387 <span type="species:ncbi:9606">participants</span>
###xml 533 545 <span type="species:ncbi:9606">participants</span>
We used genome-wide association data from up to 11 685 participants with measures of circulating LDL-cholesterol concentrations across five studies, including data for 293 461 autosomal single nucleotide polymorphisms (SNPs) with a minor allele frequency of 5% or more that passed our quality control criteria. We also used data from a second genome-wide array in up to 4337 participants from three of these five studies, with data for 290 140 SNPs. We did replication studies in two independent populations consisting of up to 4979 participants. Statistical approaches, including meta-analysis and linkage disequilibrium plots, were used to refine association signals; we analysed pooled data from all seven populations to determine the effect of each SNP on variations in circulating LDL-cholesterol concentrations.
###end p 8
###begin title 9
Findings
###end title 9
###begin p 10
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;15</sup>
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 295 297 295 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 397 400 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;33</sup>
###xml 424 427 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;20</sup>
In our initial scan, we found two SNPs (rs599839 [p=1.7x10-15] and rs4970834 [p=3.0x10-11]) that showed genome-wide statistical association with LDL cholesterol at chromosomal locus 1p13.3. The second genome screen found a third statistically associated SNP at the same locus (rs646776 [p=4.3x10-9]). Meta-analysis of data from all studies showed an association of SNPs rs599839 (combined p=1.2x10-33) and rs646776 (p=4.8x10-20) with LDL-cholesterol concentrations. SNPs rs599839 and rs646776 both explained around 1% of the variation in circulating LDL-cholesterol concentrations and were associated with about 15% of an SD change in LDL cholesterol per allele, assuming an SD of 1 mmol/L.
###end p 10
###begin title 11
Interpretation
###end title 11
###begin p 12
We found evidence for a novel locus for LDL cholesterol on chromosome 1p13.3. These results potentially provide insight into the biological mechanisms that underlie the regulation of LDL cholesterol and might help in the discovery of novel therapeutic targets for cardiovascular disease.
###end p 12
###begin title 13
Introduction
###end title 13
###begin p 14
###xml 188 189 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr"><sup>1</sup></xref>
LDL cholesterol has a causal role in the development of cardiovascular disease. Indeed, experimental studies have shown the clinical efficacy of lowering concentrations of LDL cholesterol.1 Thus, regulation of LDL cholesterol represents a fundamental target for devising additional interventional strategies to reduce the risk of cardiovascular disease. In this context, understanding the biological mechanisms that underlie metabolism and regulation of LDL cholesterol might help to identify novel therapeutic targets.
###end p 14
###begin p 15
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#8211;4</sup>
###xml 65 68 65 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib3 bib4" ref-type="bibr"><sup>2&#8211;4</sup></xref>
###xml 315 318 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5,6</sup>
###xml 315 318 315 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5 bib6" ref-type="bibr"><sup>5,6</sup></xref>
###xml 378 390 <span type="species:ncbi:9606">participants</span>
Variation in LDL-cholesterol concentrations is a polygenic trait.2-4 Integration of genome-wide technologies and epidemiological approaches could help to identify novel genetic determinants of variation in LDL-cholesterol concentrations, providing new insights into the metabolism and regulation of LDL cholesterol.5,6 We therefore did a genome-wide association study on 11 685 participants with measures of circulating LDL-cholesterol concentrations across five studies. To validate these associations, we also did replication studies in independent populations.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
Participants
###end title 17
###begin p 18
Data were gathered from five groups of individuals: two subcohorts of the EPIC-Norfolk study, the 1958 British birth cohort, the CoLaus study, and the Genetic Epidemiology of Metabolic Syndrome study.
###end p 18
###begin p 19
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 538 539 538 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr"><sup>8</sup></xref>
###xml 83 86 <span type="species:ncbi:9606">men</span>
###xml 91 96 <span type="species:ncbi:9606">women</span>
###xml 628 640 <span type="species:ncbi:9606">participants</span>
The EPIC-Norfolk study is a population-based cohort study of 25 663 white European men and women aged 39-79 years recruited in Norfolk, UK, between 1993 and 1997.7 We examined a subcohort that consisted of 2566 individuals who were randomly selected from the total cohort using a random selection algorithm. Serum total cholesterol, HDL cholesterol, and triglycerides were measured in fresh samples with the RA-1000 analyser (Bayer Diagnostics, Basingstoke, UK). LDL-cholesterol concentrations were calculated with the Friedewald formula.8 The Norwich local research ethics committee granted ethical approval for the study. All participants gave written informed consent.
###end p 19
###begin p 20
###xml 164 165 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 513 514 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 513 514 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr"><sup>8</sup></xref>
###xml 603 615 <span type="species:ncbi:9606">participants</span>
The EPIC-Norfolk obese set is a case series also derived from the EPIC-Norfolk cohort, consisting of 1685 individuals with obesity (body-mass index [BMI] >/=30 kg/m2). These cases were selected independently from the EPIC-Norfolk subcohort. Of these, 1284 cases were non-overlapping and used as a further study set. Serum total cholesterol, HDL cholesterol, and triglycerides were measured in fresh samples with the RA-1000 analyser, and LDL-cholesterol concentrations were calculated with the Friedewald formula.8 The Norwich local research ethics committee granted ethical approval for the study. All participants gave written informed consent.
###end p 20
###begin p 21
###xml 224 225 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9" ref-type="bibr"><sup>9</sup></xref>
###xml 397 399 397 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr"><sup>10</sup></xref>
###xml 721 722 721 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 721 722 721 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr"><sup>8</sup></xref>
###xml 276 288 <span type="species:ncbi:9606">participants</span>
###xml 727 739 <span type="species:ncbi:9606">participants</span>
The third study was the 1958 British birth cohort, a national population sample followed up periodically from birth to age 44-45 years, when a DNA bank was established as a national reference series for case-control studies.9 A geographically representative subsample of 1480 participants who were selected as controls for the Wellcome Trust Case-Control Consortium genome-wide-association studies10 were included in this analysis. Triglycerides, serum total cholesterol, and HDL cholesterol were measured in non-fasting serum with the Olympus model AU640 autoanalyser (Olympus Inc, Center Valley, PA, USA) by a clinical biochemistry laboratory. The concentration of LDL cholesterol was derived by the Friedewald formula.8 All participants included in this analysis gave written informed consent for the use of their DNA for non-commercial medical research purposes. Field protocols, informed consent, and this within-cohort genetic association analysis were approved by the South East NHS Multi-Centre Research Ethics Committee.
###end p 21
###begin p 22
###xml 173 175 173 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr"><sup>11</sup></xref>
###xml 1353 1354 1353 1354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 1353 1354 1353 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr"><sup>8</sup></xref>
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
###xml 474 486 <span type="species:ncbi:9606">Participants</span>
###xml 618 630 <span type="species:ncbi:9606">Participants</span>
###xml 1503 1515 <span type="species:ncbi:9606">participants</span>
Participants in the CoLaus (Cohorte Lausannoise) study were randomly selected from 56 694 individuals aged 35-75 years who were permanent residents of Lausanne, Switzerland.11 Recruitment took place between April, 2003, and March, 2006, with 6186 individuals participating in the study. Of those invited to take part, 41% actually participated. Only white European individuals (ie, individuals for whom the four grandparents were white European) were included in the study. Participants provided a detailed health questionnaire and underwent a physical examination, including measurements of anthropometric variables. Participants donated blood after a 12-h fasting period for clinical chemistry and genetic analyses. Nuclear DNA was extracted from whole blood for whole genome scan analysis. Clinical chemistry assays were done by a clinical laboratory at the Centre Hospitalier Universitaire Vaudois on fresh blood samples on a Modular P apparatus (Roche Diagnostics, Basel, Switzerland) within 2 h of blood collection. Total cholesterol was assessed by CHOD-PAP (Roche Diagnostics, Basel, Switzerland; maximum inter-batch CV 1.6%; maximum intra-batch CV 1.7%) and HDL cholesterol by CHOD-PAP, polyethylene glycol, and cyclodextrin (maximum inter-batch CV 3.6%; maximum intra-batch CV 0.9%). LDL cholesterol was calculated with the Friedewald formula.8 The study was approved by the ethical committee of the faculty of medicine of Lausanne. The study was sponsored in part by GlaxoSmithKline, and all participants were duly informed about this sponsorship, and consented for the use of biological samples and data by GlaxoSmithKline and its subsidiaries.
###end p 22
###begin p 23
###xml 218 220 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
###xml 330 332 330 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
###xml 912 913 912 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1094 1095 1094 1095 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 1094 1095 1094 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr"><sup>8</sup></xref>
###xml 615 627 <span type="species:ncbi:9606">participants</span>
###xml 1156 1168 <span type="species:ncbi:9606">participants</span>
The study population of the Genetic Epidemiology of Metabolic Syndrome (GEMS) study consisted of dyslipidaemic cases (age 20-65 years, n=1025) matched with normolipidaemic controls (n=1008) by sex and recruitment site.12 Detailed information on the GEMS study design, sampling frame, and recruitment procedures has been published.12 Serum triglycerides were measured enzymatically after hydrolysation to glycerol (Hitachi 704 analyser; Hitachi, Tokyo, Japan). HDL cholesterol was measured after the precipitation of other lipoproteins with a heparin-manganese chloride mixture (Hitachi 704 analyser). Dyslipidaemic participants were defined as those with triglycerides above the 75th percentile and HDL cholesterol below the 25th percentile, on the basis of age, sex, and country-specific distributions. Normolipidaemic controls (triglycerides <50th percentile, HDL cholesterol >50th percentile, and BMI >25 kg/m2), aged over 40 years were ascertained at the same time. Blood samples were collected after a 12-h fast and LDL-cholesterol concentration was calculated with the Friedewald formula.8 The study was sponsored in part by GlaxoSmithKline, and all participants were duly informed about this sponsorship, and consented for the use of biological samples and data by GlaxoSmithKline and its subsidiaries; the study was approved by the local ethics committees.
###end p 23
###begin p 24
###xml 362 364 362 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr"><sup>13</sup></xref>
###xml 109 121 <span type="species:ncbi:9606">participants</span>
###xml 297 309 <span type="species:ncbi:9606">participants</span>
###xml 426 429 <span type="species:ncbi:9606">men</span>
###xml 434 439 <span type="species:ncbi:9606">women</span>
###xml 687 699 <span type="species:ncbi:9606">participants</span>
For confirmation of our results, we also included another subset from EPIC-Norfolk, consisting of up to 3339 participants who did not overlap with the EPIC-Norfolk subcohort or obese set. These individuals were sequentially selected from those with DNA available for genotyping. We also used 1697 participants with DNA available for genotyping from the Ely study13 as another replication cohort-a population of white European men and women aged 35-79 years without diagnosed diabetes. This study is a population-based cohort study of the cause and pathogenesis of type 2 diabetes and related metabolic disorders in the UK. The Cambridge research ethics committee approved the study. All participants gave informed consent.
###end p 24
###begin p 25
###xml 72 82 72 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webtable 1</xref>
Selected study characteristics of all study populations are provided in webtable 1.
###end p 25
###begin title 26
Procedures
###end title 26
###begin p 27
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
###xml 57 62 <span type="species:ncbi:9606">Human</span>
Participants were genotyped with the Affymetrix GeneChip Human Mapping 500K array set (Santa Clara, CA, USA). To optimise data quality and statistical analyses, sample and single nucleotide polymorphism (SNP) quality control criteria and statistical analysis of LDL cholesterol were done within each study, independent of the other studies. For the initial genome-wide association screen, analyses were also done within study. Thus, the relevant linear regression analyses were optimised on the basis of the specific characteristics of the individual studies.
###end p 27
###begin p 28
###xml 217 219 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr"><sup>14</sup></xref>
###xml 556 557 556 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 557 558 557 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 976 978 976 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 225 237 <span type="species:ncbi:9606">participants</span>
###xml 732 744 <span type="species:ncbi:9606">participants</span>
For the EPIC-Norfolk subcohort and the EPIC-Norfolk obese set, SNP genotyping was done at the Affymetrix services laboratory (San Francisco, CA, USA). Genotypes were obtained by the BRLMM algorithm clustered by plate.14 2566 participants were genotyped in the EPIC-Norfolk subcohort and 1284 in the obese set. Individuals were excluded by use of the following sample quality control criteria: proportion of all genotypes called was less than 94%; heterozygosity was less than 23% or more than 30%; if there was more than 5.0% discordance in SNP pairs with r2=1 in HapMap; ethnic outliers; related individuals (>70% concordance with another sample); and duplicates (concordance with another DNA was >99%). These exclusions left 2417 participants in the subcohort and 1135 in the obese set. We then applied the following SNP quality control criteria. SNPs were dropped if the proportion of genotypes called was 90% or less, if they were not in Hardy-Weinberg equilibrium (p<1x10-6), and if they had a minor allele frequency (MAF) of 5% or less. We also restricted this analysis to autosomal SNPs. Therefore, there were 344 837 SNPs analysed in this genome-wide association scan for the EPIC-Norfolk subcohort. We also used the same subset of SNPs for analysis of the obese set. After sample and SNP quality control, 2269 individuals in the first subcohort and 1009 of those in the obese set had a measure of LDL cholesterol. LDL-cholesterol concentrations showed a near normal distribution in both studies. We therefore used untransformed LDL-cholesterol data. Linear regression analysis was used to assess the association between each SNP and LDL-cholesterol concentration with an additive (per allele) model (1 df) by use of PLINK version 1.0. No covariables were included in these analyses.
###end p 28
###begin p 29
###xml 137 139 137 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr"><sup>10</sup></xref>
###xml 532 534 532 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr"><sup>10</sup></xref>
###xml 589 601 <span type="species:ncbi:9606">participants</span>
For the 1958 British birth cohort, genotypes were measured with the Affymetrix GeneChip 500K array and processed by the CHIAMO algorithm.10 After sample quality control checks for contamination, non-white European identity, overall heterozygosity, relatedness, low proportion of called genotypes, and evidence of non-white European ancestry, 1480 individuals were available with genome-wide association data. SNPs were excluded from the analysis because of missing data, departures from Hardy-Weinberg equilibrium and other metrics.10 These exclusions left 461 986 SNPs for analysis. 1375 participants had data for LDL-cholesterol concentrations. Linear regression models were used to test the additive (per allele) effect of the minor allele at each locus on untransformed LDL-cholesterol concentrations. Covariables included in this analysis included sex and study-specific factors. Statistical analysis of the measured SNPs was done with Stata version 8.1.
###end p 29
###begin p 30
###xml 777 779 777 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 67 72 <span type="species:ncbi:9606">Human</span>
###xml 184 196 <span type="species:ncbi:9606">Participants</span>
###xml 295 306 <span type="species:ncbi:9606">participant</span>
###xml 499 511 <span type="species:ncbi:9606">participants</span>
###xml 705 717 <span type="species:ncbi:9606">participants</span>
###xml 863 875 <span type="species:ncbi:9606">participants</span>
For the CoLaus study, genotyping was done with Affymetrix GeneChip Human Mapping 500K array set according to the Affymetrix protocol. Genotypes were obtained with the BRLMM algorithm. Participants were removed from the analysis on the basis of the following sample quality control criteria: any participant whose sex was inconsistent with genetic data from X-linked SNPs; the proportion of genotypes called was less than 90%; having inconsistent genotypes when compared with duplicate samples. 5636 participants remained after sample quality control exclusions. We then applied SNP exclusions with the following criteria: SNPs that were monomorphic among all samples; SNPs with genotypes on less than 95% participants; SNPs that were out of Hardy-Weinberg equilibrium (p<1.0x10-7). After these quality control procedures, 370 697 SNPs remained for analysis. 5367 participants had a measure of LDL cholesterol. LDL-cholesterol concentrations showed some evidence of a non-normal distribution. Therefore, all regression analyses were done on natural log-transformed LDL-cholesterol concentrations, which showed a near normal distribution. We used linear regression analysis with an additive model adjusted for age, sex, and geographic origin. Analyses were done with PLINK version 1.0.
###end p 30
###begin p 31
###xml 451 453 451 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 69 74 <span type="species:ncbi:9606">Human</span>
###xml 268 280 <span type="species:ncbi:9606">participants</span>
###xml 602 614 <span type="species:ncbi:9606">participants</span>
For the GEMS study, genotyping was done with the Affymetrix GeneChip Human Mapping 500K array and the BRLMM calling algorithm. We excluded individuals on the basis of the same sample quality control criteria as for the CoLaus study. After sample quality control, 1847 participants from the original sample remained. We then did a SNP quality assessment, excluding SNPs that were monomorphic, those that were out of Hardy-Weinberg equilibrium (p<1.0x10-7) or if the proportion of genotypes called for each SNP was less than 95%. After SNP quality control, 359 052 SNPs were available for analysis. 1665 participants had a measure of LDL cholesterol. Again, LDL-cholesterol concentrations seemed to have a non-normal distribution. We therefore did linear regression analysis with natural log-transformed LDL-cholesterol data and an additive model with adjustment for age, sex, study site, and dyslipidaemia status. Analyses were done with PLINK version 1.0.
###end p 31
###begin p 32
###xml 620 622 620 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 824 826 824 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr"><sup>15</sup></xref>
###xml 158 170 <span type="species:ncbi:9606">Participants</span>
###xml 625 637 <span type="species:ncbi:9606">Participants</span>
To provide additional support for association signals, we examined data from the three of the five studies with a separate genotyping platform and SNP array. Participants from the EPIC-Norfolk subcohort and the EPIC-Norfolk obese set were also genotyped with the Infinium HumanHap300 SNP chip (Illumina, San Diego, CA, USA), containing 317 503 tagging SNPs derived from phase I of the International HapMap project. Of the SNPs assayed on these chips, we excluded SNPs if the proportion genotyped was 90% or less, if the MAF was 5% or less, and if the genotype distribution was out of Hardy-Weinberg equilibrium (p<1.0x10-6). Participants from the 1958 British birth cohort were genotyped with the Infinium HumanHap550 SNP chip (Illumina). Details of the sample and SNP quality control criteria have been published elsewhere.15 We did within-study analyses with an approach identical to the analyses of Affymetrix data. All Illumina genotyping was done at the Wellcome Trust Sanger Institute (Hinxton, Cambridgeshire, UK).
###end p 32
###begin p 33
The EPIC-Norfolk replication set and the Ely study were genotyped with custom TaqMan SNP assays (Applied Biosystems, Warrington, UK) at Strangeways research laboratory (University of Cambridge, Cambridge, UK).
###end p 33
###begin title 34
Statistical analysis
###end title 34
###begin p 35
###xml 419 420 411 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
To increase statistical precision in the initial genome-wide association analysis with Affymetrix data, we meta-analysed summary data from each of the five studies by use of a fixed effects model and inverse-variance weighted averages of beta coefficients with Stata version 8.2. We therefore obtained a combined estimate of the overall beta coefficient and its SE. Between-study heterogeneity was assessed with the chi2 test. To optimise data quality and statistical efficiency, we only analysed SNPs that passed sample and SNP quality control criteria in each of the five studies and that had a measure of association (beta coefficient and SE) in all five studies.
###end p 35
###begin p 36
###xml 706 708 701 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sup>
###xml 706 708 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr"><sup>16</sup></xref>
###xml 753 754 746 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1041 1051 1034 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webtable 2</xref>
###xml 1274 1275 1265 1266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
We attempted to reduce the effect of population stratification (confounding) by use of appropriate epidemiological design and statistical analysis, with ethnically homogeneous populations within each study. This approach also included adjusting for possible population stratification within study by use of geographical covariables, where appropriate. In the same context, all analyses were done conditioning on study. For each study, we also used quantile-quantile plots of the observed and expected distributions of p values to assess whether there was any evidence of distortion of the observed distribution from the null (data not shown). We also calculated an inflation factor (lambda) for each study,16 which was estimated from the mean of the chi2 tests generated on all SNPs that were tested. On the basis of data for the 293 461 tested SNPs included in the meta-analysis, the distribution of the test statistics closely followed the null distribution for each study. Accordingly, the inflation factor was close to 1 for each study (webtable 2), suggesting that the observed associations are unlikely to be the result of population stratification or other artefacts. We also used this approach to calculate an inflation factor for the combined data. Dividing the chi2 statistics for SNPs reaching genome-wide statistical association by this inflation factor did not alter the interpretation of these findings (data not shown).
###end p 36
###begin p 37
###xml 318 328 318 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webtable 2</xref>
Meta-analysis of data from Illumina assays was done in much the same way as for Affymetrix data. Quantile-quantile plots of association within study indicated that the data followed the null distribution. By use of the method of genomic control, we again found that the inflation factor was close to 1 for each study (webtable 2), suggesting that the observed associations are unlikely to be the result of population stratification.
###end p 37
###begin p 38
###xml 30 31 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 397 408 <span type="species:ncbi:9606">participant</span>
We used pairwise correlation (r2) to assess the extent of linkage disequilibrium between co-located SNPs. On the basis of linear regression analyses, we then used likelihood ratio tests to assess whether statistically associated SNPs independently contributed to the variation in LDL-cholesterol concentrations and to determine the source of any association signal. For these analyses, individual participant data were available for only four studies (no data were available for the 1958 British birth cohort). Specifically, we compared the log likelihood of a nested model (2 df) with that of the full model (3 df) by consecutively adding extra SNPs (in a log additive form) to a model containing the SNP with the strongest statistical signal from the genome-wide screen (general inheritance [2 df] form). We also did a reciprocal analysis, adding the SNP with the strongest statistical signal from the genome-wide screen (1 df form) to a model containing other SNPs showing statistical association (2 df form). All analyses were done with Stata version 8.2.
###end p 38
###begin p 39
###xml 63 65 63 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sup>
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr"><sup>17</sup></xref>
###xml 180 182 180 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sup>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr"><sup>18</sup></xref>
###xml 404 406 404 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">19</sup>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr"><sup>19</sup></xref>
###xml 991 993 988 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 991 993 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr"><sup>10</sup></xref>
We then generated a linkage disequilibrium plot with Haploview.17 Linkage disequilibrium blocks are delineated by black lines and defined with the method of Gabriel and colleagues.18 To provide a more detailed assessment of chromosomal regions showing statistical association, and to further refine the location of any association signal, we imputed SNPs on the basis of HapMap phase II data with IMPUTE.19 We used information on SNP genotypes in our studies and HapMap II data to statistically predict all SNP genotypes in a chromosomal region for all individuals. For these imputed data, association analysis was done with SNPTEST (with the full posterior probability genotype distribution) for the imputed genotypes and LDL-cholesterol data for each study separately (adding in relevant covariables). beta coefficients were combined as before. Only SNPs with a MAF of 1% or more and with a posterior-probability score more than 0.90 were considered for these imputed association analyses.10 Imputed data were not available for the GEMS study.
###end p 39
###begin p 40
###xml 573 574 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 107 118 <span type="species:ncbi:9606">participant</span>
###xml 682 693 <span type="species:ncbi:9606">participant</span>
To increase comparability between studies, we reanalysed data from CoLaus and GEMS where we had individual participant data with untransformed LDL-cholesterol data and with no covariable adjustment. We then did a meta-analysis of all studies, including the replication studies and untransformed data from CoLaus and GEMS. As before, we obtained beta coefficients and SE from each study and used a fixed effects model and inverse-variance weighting to obtain a combined estimate of the overall beta coefficient and its SE. Heterogeneity between studies was assessed with chi2 tests. Finally, we did a pooled analysis (conditioning on study) of all studies in which we had individual participant data. This analysis provided an estimate of the magnitude of the relation between these SNPs and LDL-cholesterol concentrations in a comparable way, and also provided a measure of the variation in circulating LDL-cholesterol concentrations explained by each SNP. We also used multivariable linear regression analysis to examine whether age and sex affected these associations. By use of these pooled data, we also contextualised our results as a proportion of a SD change in LDL-cholesterol concentrations. All analyses were done with Stata version 8.2. For a downloadable file of all results, including additional analyses, see .
###end p 40
###begin title 41
Role of the funding source
###end title 41
###begin p 42
This study was funded by UK Medical Research Council, Wellcome Trust, British Heart Foundation, and GlaxoSmithKline. Employees of GlaxoSmithKline contributed to the study design, data analysis, data interpretation, and writing of the report. Other sponsors of the study had no role in data collection, the study design, data analysis, data interpretation, or writing of the report. The corresponding author had full access to the data and final responsibility for the decision to submit for publication.
###end p 42
###begin title 43
Results
###end title 43
###begin p 44
###xml 254 256 254 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 258 265 258 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">table 1</xref>
###xml 341 351 341 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webtable 3</xref>
###xml 422 429 422 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">table 1</xref>
###xml 543 547 543 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOB</italic>
###xml 552 556 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 564 571 564 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,20,21</sup>
###xml 564 571 564 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib20 bib21" ref-type="bibr"><sup>2,20,21</sup></xref>
###xml 608 611 608 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;15</sup>
###xml 636 639 636 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 857 864 857 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">table 1</xref>
Data for 293 461 autosomal SNPs identified with Affymetrix were available for analysis in up to 11 685 individuals from five studies. 14 SNPs were statistically associated with circulating LDL-cholesterol concentrations at the genome-wide level (p<1.0x10-7; table 1). The 14 SNPs showed directionally consistent signals in all five studies (webtable 3). These SNPs were broadly confined to three distinct genomic regions (table 1), two of which were close to known loci involved in LDL-cholesterol metabolism (including those encompassing the APOB and APOE genes).2,20,21 Notably, two SNPs-rs599839 (p=1.7x10-15) and rs4970834 (p=3.0x10-11)-showed evidence for statistical association and were both located at chromosomal region 1p13.3. For these SNPs, there was no material evidence for heterogeneity between studies after adjustment for multiple testing (table 1).
###end p 44
###begin p 45
###xml 360 362 360 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 364 371 364 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">table 2</xref>
###xml 376 386 376 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webtable 4</xref>
###xml 579 581 579 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 175 187 <span type="species:ncbi:9606">participants</span>
Data for 290 140 SNPs identified with Illumina were available for analysis across the three studies that were assessed with these chips. For these analyses, we had up to 4337 participants with a measure of LDL-cholesterol concentration. Seven SNPs were statistically associated with circulating LDL-cholesterol concentrations at the genome-wide level (p<1.0x10-7; table 2 and webtable 4). Six of these SNPs were located in genomic regions previously linked to LDL-cholesterol metabolism. However, we also found another SNP located at chromosomal region 1p13.3 (rs646776; p=4.3x10-9).
###end p 45
###begin p 46
###xml 109 118 109 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webfigure</xref>
###xml 189 195 189 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CELSR2</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSRC1</italic>
###xml 441 450 441 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webfigure</xref>
###xml 544 545 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 545 546 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 553 563 553 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webtable 5</xref>
###xml 643 644 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 644 645 644 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 671 681 671 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webtable 5</xref>
###xml 815 822 815 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">table 1</xref>
###xml 827 834 827 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">table 2</xref>
Linkage disequilibrium plots of the three SNPs located at 1p13.3 implicated a region spanning several genes (webfigure). The strongest statistically associated SNP (rs599839) lay 3' to the CELSR2 and PSRC1 genes (the two genes are in a tail-to-tail orientation) in a 98 kb region of fragmented linkage disequilibrium. This region contained several recombination hotspots and was situated between two blocks of strong linkage disequilibrium (webfigure). SNP rs4970834 also lay in this region and in our studies was correlated with SNP rs599839 (r2=0.79; webtable 5). SNP rs646776 was also colocalised with these SNPs and was highly correlated (r2=0.94) with SNP rs599839 (webtable 5). For all three SNPs, the minor allele, with a frequency of around 19-21%, was associated with lower LDL-cholesterol concentrations (table 1 and table 2).
###end p 46
###begin p 47
###xml 315 325 315 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webtable 6</xref>
###xml 603 613 603 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webtable 6</xref>
###xml 39 51 <span type="species:ncbi:9606">participants</span>
###xml 454 466 <span type="species:ncbi:9606">participants</span>
Likelihood ratio tests of up to 10 310 participants showed that, for the Affymetrix SNPs, assuming that SNP rs599839 was the causal variant or in near complete linkage disequilibrium with the causal variant(s), inclusion of SNP rs599839 as a covariable explained the other observed SNP associations in this region (webtable 6). In an exploratory and equivalent analysis on a small subset of samples with both Affymetrix and Illumina SNP data (up to 3007 participants), we found that both SNPs rs599839 and rs646776, which are highly correlated, equally explained the association signals in this region (webtable 6). Thus, when conditioning on SNP rs599389, our results indicated that the three statistically associated SNPs might be characterising identical genetic variant(s) in this region.
###end p 47
###begin p 48
###xml 341 344 341 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;14</sup>
###xml 346 354 346 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">figure 1</xref>
###xml 359 366 359 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl3" ref-type="table">table 3</xref>
###xml 612 618 612 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CELSR2</italic>
###xml 625 633 625 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">figure 1</xref>
###xml 638 645 638 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl3" ref-type="table">table 3</xref>
###xml 753 754 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 754 755 754 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 124 136 <span type="species:ncbi:9606">participants</span>
Imputation of all SNPs with a MAF of 1% or more from our Affymetrix array and HapMap II data for this 98 kb region for 9988 participants allowed us to assess whether additional association signals might be present in this region. On the basis of these imputed data, the strongest evidence for association was found for SNP rs646776 (p=3.0x10-14; figure 1 and table 3). Indeed, within this 98 kb region, the strongest association signals from both imputed and genotyped data were localised to a 14 kb region containing a group of seven highly correlated SNPs that included the 3' untranslated region (UTR) of the CELSR2 gene (figure 1 and table 3). By use of data from HapMap, we found that SNPs rs599839 and rs646776 tag six of these seven SNPs with an r2 between 0.96 and 1.00. However, in view of the strong linkage disequilibrium, the specific source of the association signal is unlikely to be reliably differentiated between these SNPs in our data.
###end p 48
###begin p 49
###xml 164 174 164 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webtable 7</xref>
###xml 255 265 255 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webtable 7</xref>
To validate associations found in our genome-wide association screens and imputational analysis, we genotyped rs599839 and rs646776 in the two replication cohorts (webtable 7). There was again evidence of statistical association in each of these studies (webtable 7), thus corroborating our imputed results.
###end p 49
###begin p 50
###xml 284 287 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;33</sup>
###xml 289 299 289 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">webtable 7</xref>
###xml 460 463 460 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;20</sup>
###xml 535 543 535 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">figure 2</xref>
###xml 165 177 <span type="species:ncbi:9606">participants</span>
###xml 338 350 <span type="species:ncbi:9606">participants</span>
Lastly, we conducted a meta-analysis and pooled analysis of all available studies by use of a comparable analytical approach. Meta-analysis of data for up to 16 571 participants showed evidence for statistical association for SNP rs599839 with LDL-cholesterol concentrations (p=1.2x10-33; webtable 7). On the basis of data for up to 9282 participants, we found evidence for statistical association for SNP rs646776 with LDL-cholesterol concentrations (p=4.8x10-20). These associations were directionally consistent across all studies (figure 2), with no heterogeneity between studies (p=0.43 for SNP rs599839 and p=0.88 for rs646776).
###end p 50
###begin p 51
###xml 399 407 399 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">figure 2</xref>
###xml 60 71 <span type="species:ncbi:9606">participant</span>
A pooled analysis of all studies in which we had individual participant data, which consisted of 15 196 individuals for SNP rs599839 and 7952 individuals for SNP rs646776, suggested that SNPs rs599839 and rs646776 both explained around 1% of the variation in circulating LDL-cholesterol concentrations and were associated with about 15% of an SD change in LDL-cholesterol concentrations per allele (figure 2). Further adjustment for age and sex did not alter these findings (data not shown).
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 150 154 150 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4,20</sup>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4 bib20" ref-type="bibr"><sup>4,20</sup></xref>
Our data provide evidence for a locus for LDL cholesterol at chromosome region 1p13.3. This locus has not previously been related to lipid metabolism.4,20 These results could provide insight into the biological mechanisms that underlie the regulation of LDL-cholesterol concentrations and might help to identify new therapeutic targets for cardiovascular disease. The magnitude of the association was consistent across the studies we examined, and showed independent evidence for statistical association in each study.
###end p 53
###begin p 54
###xml 162 164 162 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">22</sup>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr"><sup>22</sup></xref>
###xml 330 332 330 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 345 347 345 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
Examination of the publicly available Affymetrix 500K results from the Diabetes Genetics Initiative genome-wide association scan of LDL-cholesterol concentrations22 suggests that rs599839 and rs4970834-the two most strongly associated SNPs from our Affymetrix array-also showed clear evidence for statistical association (p=9.0x10-8 and p=1.2x10-4, respectively) with LDL-cholesterol concentrations, providing independent confirmation of our findings.
###end p 54
###begin p 55
###xml 170 172 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23</sup>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr"><sup>23</sup></xref>
###xml 992 994 992 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24</sup>
###xml 992 994 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr"><sup>24</sup></xref>
###xml 1475 1477 1475 1477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24</sup>
###xml 1475 1477 1475 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr"><sup>24</sup></xref>
Our results are unlikely to be artifacts. We used several genotyping technologies, independent replication, and stringent statistical criteria to define our associations.23 The consistency of the association across heterogeneous populations also argues against a false positive association. By contrast, random error in the measurement of LDL-cholesterol concentrations might have lead to an underestimation of the magnitude of the association between these genetic variants and LDL-cholesterol concentrations. However, it is likely that our study does not have the statistical power to detect other novel genetic determinants with smaller effects on LDL-cholesterol concentrations. Even larger scale studies will be required to detect these associations. Consistent with a causal link between LDL cholesterol and risk of coronary artery disease, the locus that we identified has also shown statistical association with risk of coronary heart disease in other genome-wide association studies.24 This association is directionally consistent with our data. Specifically, our data show that minor allele carriers of these genetic variants, who made up around 20% of our populations, have lower circulating LDL-cholesterol concentrations. In keeping with this finding, a genome-wide association of coronary heart disease found that individuals with these alleles have a lower risk of developing coronary artery disease than do individuals who are homozygous for the major allele.24 In this context, our study also shows that, in addition to discovering new genetic determinants of quantitative traits, genome-wide association studies of quantitative risk factors can provide a research framework to determine the mechanism underlying association signals for relevant disease susceptibility genes.
###end p 55
###begin p 56
###xml 394 396 394 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25</sup>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25" ref-type="bibr"><sup>25</sup></xref>
Genetic variants at this locus explained around 1% of the variation in LDL-cholesterol concentrations, and were associated with about 15% of an SD change in LDL-cholesterol concentrations per allele, on the basis of a SD of around 1 mmol/L. With caveats, these variants might therefore have use as genetic tools for causal inference in Mendelian randomisation studies of cardiovascular disease.25
###end p 56
###begin p 57
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCSK9</italic>
###xml 247 260 247 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,20,21,26&#8211;28</sup>
###xml 247 260 247 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib20 bib21 bib26 bib27 bib28" ref-type="bibr"><sup>2,20,21,26&#8211;28</sup></xref>
###xml 336 343 336 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,27,29</sup>
###xml 336 343 336 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib27 bib29" ref-type="bibr"><sup>2,27,29</sup></xref>
###xml 507 513 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CELSR2</italic>
###xml 953 959 953 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CELSR2</italic>
Up to now, genetic variation at the apolipoprotein E and B genes, the LDL receptor gene, and variation at the gene encoding proprotein convertase subtilisin/kexin type 9 (PCSK9) has been consistently shown to affect LDL-cholesterol concentrations.2,20,21,26-28 Mutations in these genes are also causes of familial hypercholesterolaemia.2,27,29 Our data indicate that association signals between genetic variants at the 1p13.3 locus and LDL-cholesterol concentrations might be localised to the 3' UTR of the CELSR2 gene-the cadherin EGF LAG seven-pass G-type receptor 2. Further genetic epidemiological studies could help clarify the source of the association signal or the causal variant(s). However, because of the strong correlation between statistically associated SNPs at this gene in European populations, studies of populations with greater genetic diversity might be required to help resolve these association signals. The biological role of the CELSR2 gene is unknown. Functional studies and examination of genetic mutations in this region might help clarify the role of proteins encoded by this genomic region in lipid metabolism and disorders, including familial hypercholesterolaemia.
###end p 57
###begin title 58
Web Extra Material
###end title 58
###begin p 59
###xml 0 9 0 9 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="60">Webfigure</title>
###xml 0 9 0 9 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="60">Webfigure</title></caption>
###xml 9 106 9 106 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="61">Linkage disequilibrium plot of 200 kb genomic sequence spanning SNP rs599839 on chromosome 1p13.3</p>
###xml 325 326 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 326 327 324 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 339 340 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 340 341 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 401 402 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 402 403 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 439 440 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 440 441 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 578 580 576 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sup>
###xml 578 580 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr"><sup>18</sup></xref>
###xml 797 805 795 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">figure 1</xref>
###xml 915 917 913 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sup>
###xml 915 917 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr"><sup>17</sup></xref>
###xml 106 953 106 951 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="62">Release 22/phase II Apr 07, NCBI B36 assembly, dbSNP build 126, (CEPH Utah trios), chr1 co-ordinates 109523689-109723688. Positions of genes, SNPs genotyped in HapMap (MAF&#8805;0&#183;01) and linkage disequilibrium among SNPs (<italic>r</italic><sup>2</sup>) is shown. <italic>r</italic><sup>2</sup> values of 1&#183;0 are depicted by black diamonds, intermediate <italic>r</italic><sup>2</sup> values are represented in grey and <italic>r</italic><sup>2</sup> values of 0 as white. Linkage disequilibrium blocks are delineated by black lines and defined with the method of Gabriel and colleagues.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> The three SNPs showing genome-wide statistical association with circulating LDL-cholesterol concentrations are boxed in red. The blue line highlights the 98 kb region for which we analysed imputed data (see text and <xref rid="fig1" ref-type="fig">figure 1</xref> for details) demarcated by two blocks of high linkage disequilibrium. The plot was generated using Haploview,<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> available from the HapMap website (<ext-link xlink:href="http://www.broad.mit.edu/mpg/haploview/index.php" ext-link-type="uri">http://www.broad.mit.edu/mpg/haploview/index.php</ext-link>).</p>
###xml 955 955 953 953 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc1.pdf" mimetype="application" mime-subtype="pdf"/>
###xml 0 955 0 953 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1cc70c0N0x2dcdd20"><caption><title textid="60">Webfigure</title></caption><p textid="61">Linkage disequilibrium plot of 200 kb genomic sequence spanning SNP rs599839 on chromosome 1p13.3</p><p textid="62">Release 22/phase II Apr 07, NCBI B36 assembly, dbSNP build 126, (CEPH Utah trios), chr1 co-ordinates 109523689-109723688. Positions of genes, SNPs genotyped in HapMap (MAF&#8805;0&#183;01) and linkage disequilibrium among SNPs (<italic>r</italic><sup>2</sup>) is shown. <italic>r</italic><sup>2</sup> values of 1&#183;0 are depicted by black diamonds, intermediate <italic>r</italic><sup>2</sup> values are represented in grey and <italic>r</italic><sup>2</sup> values of 0 as white. Linkage disequilibrium blocks are delineated by black lines and defined with the method of Gabriel and colleagues.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> The three SNPs showing genome-wide statistical association with circulating LDL-cholesterol concentrations are boxed in red. The blue line highlights the 98 kb region for which we analysed imputed data (see text and <xref rid="fig1" ref-type="fig">figure 1</xref> for details) demarcated by two blocks of high linkage disequilibrium. The plot was generated using Haploview,<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> available from the HapMap website (<ext-link xlink:href="http://www.broad.mit.edu/mpg/haploview/index.php" ext-link-type="uri">http://www.broad.mit.edu/mpg/haploview/index.php</ext-link>).</p><media xlink:href="mmc1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material>
###xml 955 965 953 963 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="63">Webtable 1</title>
###xml 955 965 953 963 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="63">Webtable 1</title></caption>
###xml 965 995 963 993 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="64">Selected study characteristics</p>
###xml 995 995 993 993 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc2.pdf" mimetype="application" mime-subtype="pdf"/>
###xml 955 995 953 993 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1cc70c0N0x2dce020"><caption><title textid="63">Webtable 1</title></caption><p textid="64">Selected study characteristics</p><media xlink:href="mmc2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material>
###xml 995 1005 993 1003 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="65">Webtable 2</title>
###xml 995 1005 993 1003 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="65">Webtable 2</title></caption>
###xml 1005 1022 1003 1020 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="66">Inflation factors</p>
###xml 1022 1022 1020 1020 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc3.pdf" mimetype="application" mime-subtype="pdf"/>
###xml 995 1022 993 1020 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1cc70c0N0x2dce1a0"><caption><title textid="65">Webtable 2</title></caption><p textid="66">Inflation factors</p><media xlink:href="mmc3.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material>
###xml 1022 1032 1020 1030 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="67">Webtable 3</title>
###xml 1022 1032 1020 1030 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="67">Webtable 3</title></caption>
###xml 1103 1105 1101 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1032 1188 1030 1186 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="68">Associations between Affymetrix SNPs with a combined p value of &lt;1&#183;0&#215;10<sup>&#8722;7</sup> and circulating concentrations of LDL cholesterol in independent study populations</p>
###xml 1188 1188 1186 1186 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc4.pdf" mimetype="application" mime-subtype="pdf"/>
###xml 1022 1188 1020 1186 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1cc70c0N0x2dce320"><caption><title textid="67">Webtable 3</title></caption><p textid="68">Associations between Affymetrix SNPs with a combined p value of &lt;1&#183;0&#215;10<sup>&#8722;7</sup> and circulating concentrations of LDL cholesterol in independent study populations</p><media xlink:href="mmc4.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material>
###xml 1188 1198 1186 1196 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="69">Webtable 4</title>
###xml 1188 1198 1186 1196 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="69">Webtable 4</title></caption>
###xml 1267 1269 1265 1267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1198 1352 1196 1350 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="70">Associations between Illumina SNPs with a combined p value of &lt;1&#183;0&#215;10<sup>&#8722;7</sup> and circulating concentrations of LDL cholesterol in independent study populations</p>
###xml 1352 1352 1350 1350 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc5.pdf" mimetype="application" mime-subtype="pdf"/>
###xml 1188 1352 1186 1350 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1cc70c0N0x2e05f80"><caption><title textid="69">Webtable 4</title></caption><p textid="70">Associations between Illumina SNPs with a combined p value of &lt;1&#183;0&#215;10<sup>&#8722;7</sup> and circulating concentrations of LDL cholesterol in independent study populations</p><media xlink:href="mmc5.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material>
###xml 1352 1362 1350 1360 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="71">Webtable 5</title>
###xml 1352 1362 1350 1360 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="71">Webtable 5</title></caption>
###xml 1386 1387 1384 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1387 1388 1385 1386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1362 1420 1360 1418 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="72">Linkage disequilibrium (<italic>r</italic><sup>2</sup>) among SNPs at the 1p13.3 locus</p>
###xml 1420 1420 1418 1418 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc6.pdf" mimetype="application" mime-subtype="pdf"/>
###xml 1352 1420 1350 1418 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1cc70c0N0x2e06100"><caption><title textid="71">Webtable 5</title></caption><p textid="72">Linkage disequilibrium (<italic>r</italic><sup>2</sup>) among SNPs at the 1p13.3 locus</p><media xlink:href="mmc6.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material>
###xml 1420 1430 1418 1428 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="73">Webtable 6</title>
###xml 1420 1430 1418 1428 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="73">Webtable 6</title></caption>
###xml 1430 1575 1428 1573 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="74">Log likelihood ratio tests assessing the conditional association among SNPs at the 1p13.3 locus and circulating concentrations of LDL cholesterol</p>
###xml 1575 1575 1573 1573 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc7.pdf" mimetype="application" mime-subtype="pdf"/>
###xml 1420 1575 1418 1573 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1cc70c0N0x2e062e0"><caption><title textid="73">Webtable 6</title></caption><p textid="74">Log likelihood ratio tests assessing the conditional association among SNPs at the 1p13.3 locus and circulating concentrations of LDL cholesterol</p><media xlink:href="mmc7.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material>
###xml 1575 1585 1573 1583 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="75">Webtable 7</title>
###xml 1575 1585 1573 1583 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="75">Webtable 7</title></caption>
###xml 1585 1760 1583 1758 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="76">Association between SNPs at the 1p13.3 locus and circulating concentrations of LDL cholesterol&#8212;initial genome-wide association studies, replication studies, and meta-analysis*</p>
###xml 1760 1760 1758 1758 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc8.pdf" mimetype="application" mime-subtype="pdf"/>
###xml 1575 1760 1573 1758 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1cc70c0N0x2e06460"><caption><title textid="75">Webtable 7</title></caption><p textid="76">Association between SNPs at the 1p13.3 locus and circulating concentrations of LDL cholesterol&#8212;initial genome-wide association studies, replication studies, and meta-analysis*</p><media xlink:href="mmc8.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material>
WebfigureLinkage disequilibrium plot of 200 kb genomic sequence spanning SNP rs599839 on chromosome 1p13.3Release 22/phase II Apr 07, NCBI B36 assembly, dbSNP build 126, (CEPH Utah trios), chr1 co-ordinates 109523689-109723688. Positions of genes, SNPs genotyped in HapMap (MAF>/=0.01) and linkage disequilibrium among SNPs (r2) is shown. r2 values of 1.0 are depicted by black diamonds, intermediate r2 values are represented in grey and r2 values of 0 as white. Linkage disequilibrium blocks are delineated by black lines and defined with the method of Gabriel and colleagues.18 The three SNPs showing genome-wide statistical association with circulating LDL-cholesterol concentrations are boxed in red. The blue line highlights the 98 kb region for which we analysed imputed data (see text and figure 1 for details) demarcated by two blocks of high linkage disequilibrium. The plot was generated using Haploview,17 available from the HapMap website ().Webtable 1Selected study characteristicsWebtable 2Inflation factorsWebtable 3Associations between Affymetrix SNPs with a combined p value of <1.0x10-7 and circulating concentrations of LDL cholesterol in independent study populationsWebtable 4Associations between Illumina SNPs with a combined p value of <1.0x10-7 and circulating concentrations of LDL cholesterol in independent study populationsWebtable 5Linkage disequilibrium (r2) among SNPs at the 1p13.3 locusWebtable 6Log likelihood ratio tests assessing the conditional association among SNPs at the 1p13.3 locus and circulating concentrations of LDL cholesterolWebtable 7Association between SNPs at the 1p13.3 locus and circulating concentrations of LDL cholesterol-initial genome-wide association studies, replication studies, and meta-analysis*
###end p 59
###begin title 60
Webfigure
###end title 60
###begin p 61
Linkage disequilibrium plot of 200 kb genomic sequence spanning SNP rs599839 on chromosome 1p13.3
###end p 61
###begin p 62
###xml 219 220 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 220 221 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 233 234 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 234 235 232 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 295 296 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 296 297 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 333 334 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 334 335 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 472 474 470 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sup>
###xml 472 474 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr"><sup>18</sup></xref>
###xml 691 699 689 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">figure 1</xref>
###xml 809 811 807 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sup>
###xml 809 811 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr"><sup>17</sup></xref>
Release 22/phase II Apr 07, NCBI B36 assembly, dbSNP build 126, (CEPH Utah trios), chr1 co-ordinates 109523689-109723688. Positions of genes, SNPs genotyped in HapMap (MAF>/=0.01) and linkage disequilibrium among SNPs (r2) is shown. r2 values of 1.0 are depicted by black diamonds, intermediate r2 values are represented in grey and r2 values of 0 as white. Linkage disequilibrium blocks are delineated by black lines and defined with the method of Gabriel and colleagues.18 The three SNPs showing genome-wide statistical association with circulating LDL-cholesterol concentrations are boxed in red. The blue line highlights the 98 kb region for which we analysed imputed data (see text and figure 1 for details) demarcated by two blocks of high linkage disequilibrium. The plot was generated using Haploview,17 available from the HapMap website ().
###end p 62
###begin title 63
Webtable 1
###end title 63
###begin p 64
Selected study characteristics
###end p 64
###begin title 65
Webtable 2
###end title 65
###begin p 66
Inflation factors
###end p 66
###begin title 67
Webtable 3
###end title 67
###begin p 68
###xml 71 73 71 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
Associations between Affymetrix SNPs with a combined p value of <1.0x10-7 and circulating concentrations of LDL cholesterol in independent study populations
###end p 68
###begin title 69
Webtable 4
###end title 69
###begin p 70
###xml 69 71 69 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
Associations between Illumina SNPs with a combined p value of <1.0x10-7 and circulating concentrations of LDL cholesterol in independent study populations
###end p 70
###begin title 71
Webtable 5
###end title 71
###begin p 72
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Linkage disequilibrium (r2) among SNPs at the 1p13.3 locus
###end p 72
###begin title 73
Webtable 6
###end title 73
###begin p 74
Log likelihood ratio tests assessing the conditional association among SNPs at the 1p13.3 locus and circulating concentrations of LDL cholesterol
###end p 74
###begin title 75
Webtable 7
###end title 75
###begin p 76
Association between SNPs at the 1p13.3 locus and circulating concentrations of LDL cholesterol-initial genome-wide association studies, replication studies, and meta-analysis*
###end p 76
###begin p 77
###xml 0 15 0 15 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acknowledgments</bold>
Acknowledgments
###end p 77
###begin p 78
We acknowledge the support of the UK Medical Research Council, Wellcome Trust, British Heart Foundation (BHF), European Commission, and GlaxoSmithKline. Specifically, we acknowledge use of genotype data from the 1958 British birth cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. IB and EW acknowledge support from EU FP6 funding (contract no LSHM-CT-2003-503041). SLD is funded by the BHF. MI, IB, and PD are funded by the Wellcome Trust. Some computation was done on the Vital-IT system at the Swiss Institute of Bioinformatics. The Lausanne and GEMS study were sponsored in part by GlaxoSmithKline. The support of Allen Roses, Lefkos Middleton, and Paul Matthews is greatly appreciated.
###end p 78
###begin p 79
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Contributors</bold>
Contributors
###end p 79
###begin p 80
MSS, SLD, EW, DMW, KP, DH, DS, JHZ, KS, XY, TJ, and RL did the statistical analyses. PD and MI coordinated the genome-wide association genotyping and bioinformatics for the EPIC-Norfolk and 1958 British birth cohort studies. DMW coordinated the genome-wide association genotyping and bioinformatics for the CoLaus and GEMS studies. MS and SA contributed to replication genotyping. MSS wrote the report. All authors contributed to the study design, analysis, and interpretation of the data.
###end p 80
###begin p 81
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wellcome Trust Case Control Consortium</bold>
Wellcome Trust Case Control Consortium
###end p 81
###begin p 82
Management committee: Paul R Burton, David G Clayton, Lon R Cardon, Nick Craddock, Panos Deloukas, Audrey Duncanson, Dominic P Kwiatkowski, Mark I McCarthy, Willem H Ouwehand, Nilesh J Samani, John A Todd, Peter Donnelly (Chair).
###end p 82
###begin p 83
###xml 0 30 0 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</bold>
Conflict of interest statement
###end p 83
###begin p 84
DMW, KS, XY, VM are employees of GlaxoSmithKline. MSS and RM have received research funding from GlaxoSmithKline. SMG has consulted for GlaxoSmithKline. AK has received research funding from, has provided CME on behalf of, and has acted as a consultant to: AstraZeneca, Laboratories Fournier, Merck/Schering Plough, Novartis, Pfizer and Sanofi-Aventis, and also owns some Orion-Pharma stocks.
###end p 84
###begin title 85
References
###end title 85
###begin article-title 86
###xml 101 113 <span type="species:ncbi:9606">participants</span>
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
###end article-title 86
###begin article-title 87
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
###end article-title 87
###begin article-title 88
Genetic and environmental influences on serum lipid levels in twins
###end article-title 88
###begin article-title 89
Genetic susceptibility to myocardial infarction and coronary artery disease
###end article-title 89
###begin article-title 90
Genome-wide association studies for common diseases and complex traits
###end article-title 90
###begin article-title 91
###xml 16 21 <span type="species:ncbi:9606">human</span>
Power tools for human genetics
###end article-title 91
###begin article-title 92
EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer
###end article-title 92
###begin article-title 93
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
###end article-title 93
###begin article-title 94
Genetic information from the British 1958 birth cohort. DNA collection
###end article-title 94
###begin article-title 95
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
###end article-title 95
###begin article-title 96
Prevalence and characteristics of vitamin or dietary supplement users in Lausanne, Switzerland: the CoLaus study. Eur J Clin Nutr
###end article-title 96
###begin article-title 97
Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: The GEMS Study. Atherosclerosis
###end article-title 97
###begin article-title 98
TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population
###end article-title 98
###begin article-title 99
WTSI high-throughput genotyping quality assessment and control
###end article-title 99
###begin article-title 100
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21
###end article-title 100
###begin article-title 101
Genomic control for association studies
###end article-title 101
###begin article-title 102
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 102
###begin article-title 103
###xml 41 46 <span type="species:ncbi:9606">human</span>
The structure of haplotype blocks in the human genome
###end article-title 103
###begin article-title 104
A new multipoint method for genome-wide association studies by imputation of genotypes
###end article-title 104
###begin article-title 105
Genetics of cardiovascular diseases: from single mutations to the whole genome
###end article-title 105
###begin article-title 106
Association of apolipoprotein E genotypes with lipid levels and coronary risk
###end article-title 106
###begin article-title 107
Whole genome scan for type 2 diabetes in a Scandinavian cohort
###end article-title 107
###begin article-title 108
Replicating genotype-phenotype associations
###end article-title 108
###begin article-title 109
Genomewide association analysis of coronary artery disease
###end article-title 109
###begin article-title 110
Nature's randomised trials
###end article-title 110
###begin article-title 111
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology
###end article-title 111
###begin article-title 112
Molecular biology of PCSK9: its role in LDL metabolism
###end article-title 112
###begin article-title 113
A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol
###end article-title 113
###begin article-title 114
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk
###end article-title 114
###begin p 115
Linkage disequilibrium plot
###end p 115
###begin p 116
###xml 169 170 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 184 185 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 243 244 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 244 245 244 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 282 283 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 871 873 871 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
(A) Plot of 98 kb genomic region aligned with association signals for imputed SNPs. Positions of genes, SNPs genotyped in HapMap, and linkage disequilibrium among SNPs (r2 is shown). r2 values of 1.0 are depicted by red diamonds, intermediate r2 values are represented in pink, and r2 values of 0 as white. Aligned underneath the linkage disequilibrium plot is a graph showing the association signal for each of the 71 SNPs which could be imputed from our data. The plot was generated with HapMap (release 22/phase II Apr 07, NCBI B36 assembly, dbSNP build 126, [CEPH Utah trios], chr1 co-ordinates 109541887-109640441). This plot illustrates that the strongest association signals are localised to a 14 kb region shown in detail in (B). Imputed SNPs that were statistically associated with circulating concentrations of LDL cholesterol at the genome-wide level (p<1.0x10-7) are boxed.
###end p 116
###begin p 117
Association between SNPs at the 1p13.3 locus and circulating concentrations of LDL cholesterol
###end p 117
###begin p 118
For individual studies beta coefficients are depicted by black boxes and spanned by 95% CI. Diamonds represent overall beta coefficients for each SNP and the width of the diamonds delineate their 95% CI. Corresponding values for each independent study and for the overall estimate are given to the right of the plot.
###end p 118
###begin p 119
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 196 208 <span type="species:ncbi:9606">participants</span>
Statistical associations (p<1.0x10-7) between Affymetrix SNPs and circulating concentrations of LDL cholesterol in a genome-wide meta-analysis of five study populations consisting of up to 11 685 participants
###end p 119
###begin p 120
On basis of NCBI Build 36.2.
###end p 120
###begin p 121
On basis of EPIC-Norfolk sub-cohort: minor allele corresponds to forward strand of NCBI Build 36.2.
###end p 121
###begin p 122
beta coefficients represent the change in LDL-cholesterol concentration per additional minor allele.
###end p 122
###begin p 123
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 196 208 <span type="species:ncbi:9606">participants</span>
Statistical associations (p<1.0x10-7) between Illumina SNPs and circulating concentrations of LDL cholesterol in a genome-wide meta-analysis of three UK study populations consisting of up to 4337 participants
###end p 123
###begin p 124
On basis of NCBI Build 36.2.
###end p 124
###begin p 125
On basis of EPIC-Norfolk subcohort; minor allele corresponds to forward strand of NCBI Build 36.2.
###end p 125
###begin p 126
beta coefficients represent the change in LDL-cholesterol concentration per additional minor allele.
###end p 126
###begin p 127
###xml 66 68 66 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 187 199 <span type="species:ncbi:9606">participants</span>
Imputed SNPs showing genome-wide statistical association (p<1.0x10-7) with circulating concentrations of LDL cholesterol; meta-analysis of four study populations consisting of up to 9988 participants
###end p 127
###begin p 128
UTR=untranslated region.
###end p 128
###begin p 129
double dagger beta coefficients represent the change in LDL-cholesterol concentration per additional minor allele.
###end p 129
###begin p 130
On basis of NCBI Build 36.2.
###end p 130
###begin p 131
On basis of EPIC-Norfolk subcohort; minor allele corresponds to forward strand of NCBI Build 36.2.
###end p 131

